Qube Research & Technologies (QRT)’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-363,205
Closed -$21.1M – 4007
2026
Q2
$21.1M Buy
363,205
+217,834
+150% +$11.8M 0.02% 889
2026
Q1
$8.45M Sell
145,371
-61,719
-30% -$3.35M 0.01% 1380
2025
Q4
$9.6M Sell
207,090
-346,759
-63% -$15.5M 0.01% 1377
2025
Q3
$19.9M Sell
553,849
-255,681
-32% -$8.47M 0.02% 894
2025
Q2
$26.3M Buy
+809,530
New +$26.5M 0.03% 737
2025
Q1
– Sell
-77,274
Closed -$6.33M – 3784
2024
Q4
$6.33M Buy
+77,274
New +$7.67M 0.01% 1359
2022
Q3
– Sell
-13,820
Closed -$301K – 2877
2022
Q2
$301K Buy
+13,820
New +$320K ﹤0.01% 1593

Other funds holding PCVX

Qube Research & Technologies (QRT)'s PCVX Position: Q3 2026 in Review

Qube Research & Technologies (QRT) sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 363,205 shares — an estimated $21.1M sold.

Qube Research & Technologies (QRT) first reported a position in PCVX in Q2 2022 and held it in 7 quarters. The position peaked at $26.3M in Q2 2025. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Qube Research & Technologies (QRT) reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 363,205 Vaxcyte shares in Q3 2026, an estimated $21.1M.
  • Qube Research & Technologies (QRT) first reported a position in Vaxcyte in Q2 2022 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Vaxcyte position peaked at $26.3M in Q2 2025.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.